Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REMIMAZOLAM vs RESMETIROM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REMIMAZOLAM vs RESMETIROM: Safety Overview

Metric REMIMAZOLAM RESMETIROM
Total FAERS Reports 137 881
Deaths Reported 3 26
Death Rate 2.2% 3.0%
Hospitalizations 24 50
Average Patient Age 60.4 yrs 58.1 yrs
% Female Patients 41.5% 65.3%
FDA Approval Date Oct 6, 2020 Mar 14, 2024
Manufacturer Acacia Pharma, Ltd. Madrigal Pharmaceuticals, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription